Winfried Randerath

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 522 citations · Full text

Inbuild Trial, Parallel-group Trial, Advanced Lung Disease +5

Non-CPAP therapies in obstructive sleep apnoea

Winfried Randerath, Johan Verbraecken, Stefan Andreas et al. · European Respiratory Journal · 2011 · 373 citations · Full text

Breathing Disorders, Surgery, Orthopaedic Surgery +16

Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep

Winfried Randerath, Johan Verbraecken, Stefan Andreas et al. · European Respiratory Journal · 2016 · 331 citations · Full text

Asthma, Sleep Disorders, Sleep Health +21

An Individually Adjustable Oral Appliance vs Continuous Positive Airway Pressure in Mild-to-Moderate Obstructive Sleep Apnea Syndrome

Winfried Randerath, M. Heise, Rolf Hinz et al. · CHEST Journal · 2002 · 256 citations

Sleep, Sleep Disorder, Obstructive Sleep Apnea +5

K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways

Matthias Scheffler, Michaela A. Ihle, Rebecca Hein et al. · Journal of Thoracic Oncology · 2018 · 247 citations · Full text